Human dosimetry of carbon-11 labeled N-butan-2-yl-1-(2-chlorophenyl)-N-methylisoquinoline-3-carboxamide extrapolated from whole-body distribution kinetics and radiometabolism in rats

Pauliina Luoto, Iina Laitinen, Sami Suilamo, Kjell Någren, Anne Roivainen

7 Citations (Scopus)

Abstract

Carbon-11 labeled N-butan-2-yl-1-(2-chlorophenyl)-N-methylisoquinoline-3-carboxamide ([11C]PK11195) is a peripheral benzodiazepine receptor (PBR) antagonist that is used as a positron emission tomography (PET) radiopharmaceutical for neuroinflammatory imaging. This study was designed to investigate the radiation dosimetry of [11C]PK11195.
Original languageEnglish
JournalMolecular Imaging and Biology
Volume12
Issue number4
Pages (from-to)435-42
Number of pages8
ISSN1536-1632
DOIs
Publication statusPublished - 1 Aug 2010

Fingerprint

Dive into the research topics of 'Human dosimetry of carbon-11 labeled N-butan-2-yl-1-(2-chlorophenyl)-N-methylisoquinoline-3-carboxamide extrapolated from whole-body distribution kinetics and radiometabolism in rats'. Together they form a unique fingerprint.

Cite this